Colorectal Cancer

Vascular Endothelial Growth Factor is Prognostic Factor

Published in Cancer Weekly, September 26th, 2000

Vascular endothelial growth factor (VEGF) marks survival and outcome in some patients with malignant colorectal tumors, according to a study reported by cancer researchers in London, England.

In fact, medical practitioners who find increased expression of this growth factor could potentially identify colorectal cancer patients who are node-negative but need adjuvant cancer therapies, E. Tsiompanou and colleagues reported at the British Cancer Research Meeting 2000.

The title of their presentation was "Immunohistochemical Expression of Vascular Endothelial Growth Factor (VEGF) and Vessel Counting as Prognostic Indicators in Node-Negative Colorectal...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2000-09-26)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry